Skip to main content

Role of TIPS and Surgery in Prevention of Rebleeding

  • Chapter
  • First Online:
Variceal Hemorrhage

Abstract

Porto-caval shunting has consistently been found to be the most effective treatment to prevent variceal bleeding. Shunting has over other treatments the advantage of normalizing portal pressure, which relieves and/or prevents not only rebleeding but also the other complications of portal hypertension. Surgical techniques can be classified into three main categories: shunting techniques either total or selective, selective variceal decompression, and devascularization procedures. As a whole, shunting was more effective than alternative treatments in preventing rebleeding, though survival was not improved and the incidence of HE was increased.

Surgical shunting has been virtually abandoned because of the development of interventional radiology techniques, mainly trans-jugular intrahepatic porto-systemic shunt (TIPS).

Whenever possible, liver transplantation should be considered in these patients whose liver function is usually poor. When it is contraindicated as well as in patients on the waiting list, or the few whose liver function is fairly preserved, a shunting procedure should be considered.

Nowadays, whenever a shunting procedure is considered needed, TIPS with PTFE-covered stents should be preferred to surgery because it avoids the complications of laparotomy, it does not hamper the chance for transplantation, and it can be reduced in diameter or occluded if needed because of the occurrence of refractory hepatic encephalopathy. Only in the few situations where TIPS cannot be performed, e.g., complete portal vein obstruction or cavernoma, devascularization techniques can be attempted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–9.

    Article  PubMed  Google Scholar 

  2. D’Amico G, De Franchis R, A cooperative study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599–612.

    Article  PubMed  Google Scholar 

  3. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5:645–63.

    Article  PubMed  Google Scholar 

  4. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–54.

    PubMed  Google Scholar 

  5. Jackson FC, Perrin EB, Felix RW, Smith AG. A clinical investigation of the portacaval shunt: survival analysis of the therapeutic operation. Ann Surg. 1971;174:672–701.

    Article  CAS  PubMed  Google Scholar 

  6. Resnick RH, Iber FL, Ishiara A, Chalmers T, Zimmermann H, The Boston Inter-Hospital Liver Group. A controlled study of the therapeutic portacaval shunt. Gastroenterology. 1974;67:843–57.

    CAS  PubMed  Google Scholar 

  7. Rueff B, Prandi D, Sicot J, Degos JP, Sicot C, Maillard JN, et al. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet. 1976;2:655–9.

    Article  Google Scholar 

  8. Reynolds TB, Donovan AJ, Mikkelsen WP, Redeker AJ, Turril FL, Weiner JM. Results of a 12-year randomized trial of portacaval shunt in patients with a alcoholic liver disease and bleeding varices. Gastroenterology. 1981;80:1005–11.

    CAS  PubMed  Google Scholar 

  9. Mehigan DG, Zuidema GD, Cameron JL. The incidence of shunt occlusion following portosystemic decompression. Surg Gynecol Obstet. 1980;150:661–3.

    CAS  PubMed  Google Scholar 

  10. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters: clinical and hemodynamic perspectives. Ann Surg. 1986;204:356–63.

    Article  CAS  PubMed  Google Scholar 

  11. Bismuth H, Franco D, Hepp I. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg. 1974;179:209–18.

    Article  CAS  PubMed  Google Scholar 

  12. Inokuchi K, Beppu K, Koyanagi N, Nagamine K, Hashizume M, Iwanaga T, et al. Fifteen years’ experience with left gastric venous caval shunt for esophageal varices. World J Surg. 1984;8:716–21.

    Article  CAS  PubMed  Google Scholar 

  13. Inokuchi K, Cooperative Study Group of Portal Hypertension in Japan. Improved survival after prophylactic portal non decompressive surgery for esophageal varices. Hepatology. 1990;12:1–6.

    Article  CAS  PubMed  Google Scholar 

  14. Boerema I, Klopper PJ, Holscher AA. Transabdominal ligation-resection of the esophagus in cases of bleeding esophageal varices. Surgery. 1970;67:409–13.

    CAS  PubMed  Google Scholar 

  15. Prioton JB, Feneyrou B, Michel H, Bories P, Bertrand L, Blanc F. Long term results after portal disconnection of the esophagus using an anastomotic button for bleeding esophageal varices in cirrhosis. Surg Gynecol Obstet. 1986;163:121–6.

    CAS  PubMed  Google Scholar 

  16. Walker RM. Esophageal transection for bleeding varices. Surg Gynecol Obstet. 1964;118:323–9.

    CAS  PubMed  Google Scholar 

  17. Tanner NC. Direct operations in the treatment of complications of portal hypertension. J Int Coll Surg. 1961;36:308–14.

    CAS  PubMed  Google Scholar 

  18. Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg. 1973;66:677–85.

    CAS  PubMed  Google Scholar 

  19. Rikkers LF, Rudman D, Galambos JT, Fulenwider JT, Millikan WJ, Kutner M, et al. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg. 1978;188:271–82.

    Article  CAS  PubMed  Google Scholar 

  20. Reichle FA, Fahmy WF, Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg. 1979;137:13–21.

    Article  CAS  PubMed  Google Scholar 

  21. Fischer JE, Bower RH, Atamian S, Welling R. Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg. 1981;194:531–44.

    Article  CAS  PubMed  Google Scholar 

  22. Langer B, Taylor BR, Mackenzie DR, Gilas T, Stone RM, Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology. 1985;88:424–9.

    CAS  PubMed  Google Scholar 

  23. Millikan WJ, Warren WD, Henderson JM, Smith III RB, Salam AA, Galambos JT, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg. 1985;201:712–22.

    Article  PubMed  Google Scholar 

  24. Harley HA, Morgan T, Redeker AG, Reynolds TB, Villamil F, Weiner JM, et al. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology. 1986;91:802–9.

    CAS  PubMed  Google Scholar 

  25. Grace ND, Conn HO, Resnick RH, Groszmann RJ, Atterbury CE, Wright SC, et al. Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology. 1988;8:1475–81.

    Article  CAS  PubMed  Google Scholar 

  26. Rikkers LF, Burnett DA, Volentine GD, Buchi KN, Cormier RA. Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg. 1987;206:261–71.

    Article  CAS  PubMed  Google Scholar 

  27. Terés J, Bordas JM, Bravo D, Visa J, Grande L, Garcia-Valdecasas JC, et al. Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology. 1987;7:430–6.

    Article  PubMed  Google Scholar 

  28. Henderson JM, Kutner MH, Millikan Jr WJ, Galambos JT, Riepe SP, Brooks WS, et al. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med. 1990;112:262–9.

    Article  CAS  PubMed  Google Scholar 

  29. Planas R, Boix J, Broggi M, Cabré E, Gomes-Vieira MC, Morillas R, et al. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1991;100:1078–86.

    CAS  PubMed  Google Scholar 

  30. Orozco H, Mercado MA, Chan C, Guillén-Navarro E, López-Martínez LM. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years. Ann Surg. 2000;232:216–9.

    Article  CAS  PubMed  Google Scholar 

  31. Isaksson B, Jeppsson B, Bengtsson F, Hannesson P, Herlin P, Bengmark S. Mesocaval shunt or repeated sclerotherapy: effects on rebleeding and encephalopathy–a randomized trial. Surgery. 1995;117:498–504.

    Article  CAS  PubMed  Google Scholar 

  32. Santambrogio R, Opocher E, Costa M, Bruno S, Ceretti AP, Spina GP. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past. World J Gastroenterol. 2006;12:6331–8.

    PubMed  Google Scholar 

  33. Khan SA, Tudur Smith C, Williamson PR, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis (review). Cochrane Database Syst Rev. 2006;4, CD000553.

    PubMed  Google Scholar 

  34. Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92:1112–4.

    CAS  PubMed  Google Scholar 

  35. Colapinto RF, Stronell RD, Gildiner M, Ritchie AC, Langer B, Taylor BR, et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. Am J Roentgenol. 1983;140:709–14.

    Article  CAS  Google Scholar 

  36. Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portacaval shunt stents: early experience in the dog. Am J Roentgenol. 1985;145:821–5.

    Article  CAS  Google Scholar 

  37. Richter GM, Noeldge G, Palmaz JC, Roessle M, Slegerstetter V, Franke M, et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology. 1990;174:1027–30.

    CAS  PubMed  Google Scholar 

  38. Otal P, Smayra T, Bureau C, Peron JM, Chabbert V, Chemla P, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. Am J Roentgenol. 2002;178:141–7.

    Article  Google Scholar 

  39. Bureau C, Garcia-pagan JC, Otal P, Pomier-layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–75.

    Article  PubMed  Google Scholar 

  40. Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27:742–7.

    Article  CAS  PubMed  Google Scholar 

  41. Perelló A, García-Pagán JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132–9.

    Article  PubMed  Google Scholar 

  42. Blum U, Haag K, Rössle M, Ochs A, Gabelmann A, Boos S, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 1995;195:153–7.

    CAS  PubMed  Google Scholar 

  43. Barton RE, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS: short- and long-term results: a survey of 1750 patients. Semin Intervent Radiol. 1995;12:364–7.

    Article  Google Scholar 

  44. Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver. 1998;18:73–89.

    Article  PubMed  Google Scholar 

  45. Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron JM, Pierragi MT, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology. 1997;25:1064–9.

    Article  CAS  PubMed  Google Scholar 

  46. Bureau C, Otal P, Chabbert V, Péron JM, Rousseau H, Vinel JP. Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent. Hepatology. 2002;36:1554.

    PubMed  Google Scholar 

  47. Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology. 1998;115:110–5.

    Article  CAS  PubMed  Google Scholar 

  48. Maleux G, Verslype C, Heye S, Wilms G, Marchal G, Nevens F. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts. Am J Roentgenol. 2007;188:659–64.

    Article  Google Scholar 

  49. Sanyal AJ, Freedman AM, Purdum III PP. TIPS-associated hemolysis and encephalopathy. Ann Intern Med. 1992;117:443–4.

    Article  CAS  PubMed  Google Scholar 

  50. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1996;110:832–9.

    Article  CAS  PubMed  Google Scholar 

  51. Sanyal AJ, Freedman AM, Velimir A, Purdum III PP, Shiffman ML, Cole PE, et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized controlled trial. Ann Intern Med. 1997;126:849–57.

    Article  CAS  PubMed  Google Scholar 

  52. Cello JP, Ring EJ, Olcott EW, Koch J, Gordon E, Sandhu J, et al. Endoscopic sclerotherapy compared with percutaneaous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized controlled trial. Ann Intern Med. 1997;126:858–65.

    Article  CAS  PubMed  Google Scholar 

  53. Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology. 1998;27:40–5.

    Article  Google Scholar 

  54. Garcia-Villareal L, Martinez-Lagares F, Sierra A, Guevara C, Marrero JM, Jimenez E, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology. 1999;29:27–32.

    Article  Google Scholar 

  55. Narahara Y, Kanazawa H, Kawamata H, Tada N, Saitoh H, Matsuzaka S, et al. A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res. 2001;21:189–98.

    Article  PubMed  Google Scholar 

  56. Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology. 1997;26:1115–22.

    CAS  PubMed  Google Scholar 

  57. Pomier-Layrargues G, Villeneuve JP, Deschenes M, Bui B, Perreault P, Fenyves D, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut. 2001;48:390–6.

    Article  CAS  PubMed  Google Scholar 

  58. Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy. 2002;34:690–7.

    Article  CAS  PubMed  Google Scholar 

  59. Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, et al. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Scand J Gastroenterol. 2002;37:338–43.

    Article  PubMed  Google Scholar 

  60. Groupe d’Etude des Anastomoses Intra-Hépatiques. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial (abstract). Hepatology. 1995;22:A297.

    Google Scholar 

  61. Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding. Gastroenterology. 1997;113:1623–31.

    Article  CAS  PubMed  Google Scholar 

  62. Rössle M, Deibert P, Haag K, Ochs A, Olschweski M, Siegerstetter V, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997;249:1043–9.

    Article  Google Scholar 

  63. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Mointinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002;35:385–92.

    Article  PubMed  Google Scholar 

  64. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portoystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology. 1999;30:612–22.

    Article  CAS  PubMed  Google Scholar 

  65. Luca A, D’Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology. 1999;212:411–21.

    Article  CAS  PubMed  Google Scholar 

  66. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol. 2002;37:249–52.

    Article  CAS  PubMed  Google Scholar 

  67. Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg. 1996;224:378–84.

    Article  CAS  PubMed  Google Scholar 

  68. Rosemurgy AS, Serafini FM, Zweibel BR, Black TJ, Kudryk BT, Nord HJ, et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg. 2000;4:589–97.

    Article  CAS  PubMed  Google Scholar 

  69. Rosemurgy AS, Bloomston M, Clark WC, Thometz DP, Zervos EE. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg. 2005;241:238–46.

    Article  PubMed  Google Scholar 

  70. Rosemurgy AS, Frohman HA, Teta AF, Luberice K, Ross SB. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg. 2012;214:445–53.

    Article  PubMed  Google Scholar 

  71. Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643–51.

    Article  PubMed  Google Scholar 

  72. Rubenstein JH, Eisen GM, Inadomi JM. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol. 2004;99:1274–88.

    Article  PubMed  Google Scholar 

  73. Russo MW, Zacks SL, Sandler RS, Brown RS. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology. 2000;31:358–63.

    Article  CAS  PubMed  Google Scholar 

  74. Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol. 2008;48:407–14.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Ingrand P, Gournay J, Bernard P, Oberti F, Bernard-Chabert B, Pauwels A, et al. Management of digestive bleeding related to portal hypertension in cirrhotic patients: a French multicenter cross-sectional practice survey. World J Gastroenterol. 2006;12:7810–4.

    PubMed  Google Scholar 

  76. de Franchis R, Faculty BV. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Pierre Vinel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bureau, C., Vinel, JP. (2014). Role of TIPS and Surgery in Prevention of Rebleeding. In: de Franchis, R., Dell’Era, A. (eds) Variceal Hemorrhage. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0002-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0002-2_17

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0001-5

  • Online ISBN: 978-1-4939-0002-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics